Year in review #ACR22
IV Tocilizumab FDA approved in GCA!!
Randomized trial of iv tocilizumab in PMR - 101 pts. Steroid taper was quicker.
https://t.co/BQT2H8LEFk
@rheumnow https://t.co/4KAYrz1IES
Links:
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia R…
http://bit.ly/3fXngQq
12-11-2022